Copyright Reports & Markets. All rights reserved.

Global Bacterial Vaginosis Drugs Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Bacterial Vaginosis Drugs

      • 1.1 Definition of Bacterial Vaginosis Drugs
      • 1.2 Bacterial Vaginosis Drugs Segment by Type
        • 1.2.1 Global Bacterial Vaginosis Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Topical
      • 1.3 Bacterial Vaginosis Drugs Segment by Applications
        • 1.3.1 Global Bacterial Vaginosis Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Pelvic Inflammatory Disease
        • 1.3.3 Preterm Delivery of Infants
        • 1.3.4 Urinary Tract Infection
        • 1.3.5 Sexually Transmitted Diseases (STD)
      • 1.4 Global Bacterial Vaginosis Drugs Overall Market
        • 1.4.1 Global Bacterial Vaginosis Drugs Revenue (2014-2025)
        • 1.4.2 Global Bacterial Vaginosis Drugs Production (2014-2025)
        • 1.4.3 North America Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Bacterial Vaginosis Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Bacterial Vaginosis Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Bacterial Vaginosis Drugs
      • 2.3 Manufacturing Process Analysis of Bacterial Vaginosis Drugs
      • 2.4 Industry Chain Structure of Bacterial Vaginosis Drugs

      3 Development and Manufacturing Plants Analysis of Bacterial Vaginosis Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Bacterial Vaginosis Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Bacterial Vaginosis Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Bacterial Vaginosis Drugs Production and Capacity Analysis
      • 4.2 Bacterial Vaginosis Drugs Revenue Analysis
      • 4.3 Bacterial Vaginosis Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Bacterial Vaginosis Drugs Regional Market Analysis

      • 5.1 Bacterial Vaginosis Drugs Production by Regions
        • 5.1.1 Global Bacterial Vaginosis Drugs Production by Regions
        • 5.1.2 Global Bacterial Vaginosis Drugs Revenue by Regions
      • 5.2 Bacterial Vaginosis Drugs Consumption by Regions
      • 5.3 North America Bacterial Vaginosis Drugs Market Analysis
        • 5.3.1 North America Bacterial Vaginosis Drugs Production
        • 5.3.2 North America Bacterial Vaginosis Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Bacterial Vaginosis Drugs Import and Export
      • 5.4 Europe Bacterial Vaginosis Drugs Market Analysis
        • 5.4.1 Europe Bacterial Vaginosis Drugs Production
        • 5.4.2 Europe Bacterial Vaginosis Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Bacterial Vaginosis Drugs Import and Export
      • 5.5 China Bacterial Vaginosis Drugs Market Analysis
        • 5.5.1 China Bacterial Vaginosis Drugs Production
        • 5.5.2 China Bacterial Vaginosis Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Bacterial Vaginosis Drugs Import and Export
      • 5.6 Japan Bacterial Vaginosis Drugs Market Analysis
        • 5.6.1 Japan Bacterial Vaginosis Drugs Production
        • 5.6.2 Japan Bacterial Vaginosis Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Bacterial Vaginosis Drugs Import and Export
      • 5.7 Southeast Asia Bacterial Vaginosis Drugs Market Analysis
        • 5.7.1 Southeast Asia Bacterial Vaginosis Drugs Production
        • 5.7.2 Southeast Asia Bacterial Vaginosis Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Bacterial Vaginosis Drugs Import and Export
      • 5.8 India Bacterial Vaginosis Drugs Market Analysis
        • 5.8.1 India Bacterial Vaginosis Drugs Production
        • 5.8.2 India Bacterial Vaginosis Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Bacterial Vaginosis Drugs Import and Export

      6 Bacterial Vaginosis Drugs Segment Market Analysis (by Type)

      • 6.1 Global Bacterial Vaginosis Drugs Production by Type
      • 6.2 Global Bacterial Vaginosis Drugs Revenue by Type
      • 6.3 Bacterial Vaginosis Drugs Price by Type

      7 Bacterial Vaginosis Drugs Segment Market Analysis (by Application)

      • 7.1 Global Bacterial Vaginosis Drugs Consumption by Application
      • 7.2 Global Bacterial Vaginosis Drugs Consumption Market Share by Application (2014-2019)

      8 Bacterial Vaginosis Drugs Major Manufacturers Analysis

      • 8.1 Bayer
        • 8.1.1 Bayer Bacterial Vaginosis Drugs Production Sites and Area Served
        • 8.1.2 Bayer Product Introduction, Application and Specification
        • 8.1.3 Bayer Bacterial Vaginosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Pfizer
        • 8.2.1 Pfizer Bacterial Vaginosis Drugs Production Sites and Area Served
        • 8.2.2 Pfizer Product Introduction, Application and Specification
        • 8.2.3 Pfizer Bacterial Vaginosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sanofi
        • 8.3.1 Sanofi Bacterial Vaginosis Drugs Production Sites and Area Served
        • 8.3.2 Sanofi Product Introduction, Application and Specification
        • 8.3.3 Sanofi Bacterial Vaginosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Starpharma Holdings
        • 8.4.1 Starpharma Holdings Bacterial Vaginosis Drugs Production Sites and Area Served
        • 8.4.2 Starpharma Holdings Product Introduction, Application and Specification
        • 8.4.3 Starpharma Holdings Bacterial Vaginosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served

      9 Development Trend of Analysis of Bacterial Vaginosis Drugs Market

      • 9.1 Global Bacterial Vaginosis Drugs Market Trend Analysis
        • 9.1.1 Global Bacterial Vaginosis Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Bacterial Vaginosis Drugs Regional Market Trend
        • 9.2.1 North America Bacterial Vaginosis Drugs Forecast 2019-2025
        • 9.2.2 Europe Bacterial Vaginosis Drugs Forecast 2019-2025
        • 9.2.3 China Bacterial Vaginosis Drugs Forecast 2019-2025
        • 9.2.4 Japan Bacterial Vaginosis Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Bacterial Vaginosis Drugs Forecast 2019-2025
        • 9.2.6 India Bacterial Vaginosis Drugs Forecast 2019-2025
      • 9.3 Bacterial Vaginosis Drugs Market Trend (Product Type)
      • 9.4 Bacterial Vaginosis Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Bacterial Vaginosis Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis include the use of probiotics and medication. Common drug classes include lincosamide antibiotics and nitroimidazole antibiotics.
        One driver in the market is unmet demand in BV treatment market. Unmet demand in the treatment of BV has created great opportunity for the market players. There is huge unmet need in the treatment of BV, especially the recurrent form of the disease. BV is the most common vaginal infection in the women of child bearing age group. Despite being highly prevalent in nature, little has been done in the field. When left untreated, it may lead to severe infections, especially in the case of pregnant women such as preterm births. rising awareness about women's health as one of the primary growth factors for the bacterial vaginosis drugs market. Owing to recent advancements in healthcare and the initiatives taken by the government and non-government organizations to increase the awareness about health of women, the demand for pharmaceuticals related to disorders in women will witness a significant increase in the coming years. Additionally, support from government is also a key driver.

        The global Bacterial Vaginosis Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Bacterial Vaginosis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bacterial Vaginosis Drugs market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Bacterial Vaginosis Drugs in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Bacterial Vaginosis Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Bayer
        Pfizer
        Sanofi
        Starpharma Holdings
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Oral
        Topical

        Segment by Application
        Pelvic Inflammatory Disease
        Preterm Delivery of Infants
        Urinary Tract Infection
        Sexually Transmitted Diseases (STD)

        Buy now